Worldwide, the rising awareness for preventive medicine to prevent bacterial diseases is the foremost factor driving the bacterial vaccines market. Bacterial vaccines contain mild or killed form of bacteria that activate the body’s immune system.
The global bacterial vaccines market is segmented on the basis of type of vaccine, route of administration, indication, distribution channel, and region. Based on type of vaccine, some key segments of the global bacterial vaccine market are capsular polysaccharide vaccines, purified protein vaccines, toxoid vaccines, killed bacterial vaccines, and live attenuated bacterial vaccines. By indication, the global bacterial vaccines market can be segmented into tuberculosis, cholera, anthrax, influenza, tetanus, meningitis, typhoid, and others. By route of administration, the global bacterial vaccines market is divided into oral, intranasal, and injectable.
The report serves to be valuable guide for participants interested in the global bacterial vaccines market. The succinct analysis of market drivers, restraints, and opportunities, along with a detailed discussion of competitive scenario and geographical distribution are key highlights of the report. Market growth rate projections and revenue share of key segments in the bacterial vaccines market are some other valuable features of this report.
Worldwide, governments and health departments are taking substantial efforts to prevent infectious diseases. Awareness programs, availability of state-run vaccination programs, and home vaccination services are some initiatives undertaken by governments and health departments that are helping to prevent infectious diseases such as bacterial diseases. This is indirectly benefitting the global bacterial vaccines market.
Over the past few decades, in emerging economies, governments as well as non-government organizations have taken massive efforts to raise awareness for preventive medicine. Programs to reach out to uneducated people especially in rural areas has been a key aim of such initiatives. Such initiatives have received help from volunteers who undertake strenuous jobs to walk to unconnected remote places to spread awareness for preventive medicine against infectious diseases. This is a key factor boosting the bacterial vaccines market in emerging economies of the world.
Geography-wise, the global bacterial vaccines market can be segmented into North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa. North America, among them, is a leading region for bacterial vaccines. High awareness for preventive medicine and vast efforts from governments, in terms of hospitals and clinics to render preventive medicine are fuelling the bacterial vaccines market in the region. For example, in the U.S., The Department of Health and Human Services (HHS) takes massive efforts to ensure preventive medicine for infectious diseases is available to all.
Europe is anticipated to be the second-leading market for bacterial vaccines over the forecast period. This is mainly because of substantial initiatives by governments to ensure preventive medicine is available for all for deadly infectious diseases.
Key companies operating in the global bacterial vaccines market include Emergent BioDefense Operations Lansing LLC, Sanofi-Aventis U.S. LLC, Wyeth Pharmaceuticals Inc., Merck & Co. Inc., Sanofi S.A., PaxVax Inc., GlaxoSmithKline plc, Serum Institute of India Ltd., and Pfizer Inc.